What exists today?
LastDose and PulseTrace are available as Android downloads. The apps can work together, and a shared Pro plan offers monthly, yearly, or lifetime access.
Independent thinking.
Shared possibilities.
Explore the technology behind LastDose and PulseTrace, and help shape what comes next. We’re open to product distribution, technical collaboration, and aligned investment.
The opportunityBuilt products.
Built products.
Room to go further.
An independent studio working at the intersection of on-device sensing and useful personal software.
What makes the approach different?
In-house biosignal processing runs on the phone. Local records, encrypted backup options, and a direct connection between the two apps form the foundation of the product experience.
What could come next?
We’re exploring distribution partnerships and the possibility of licensing our technology. SDK packaging and enterprise integrations are future opportunities, not products currently offered for download. Local Favor is also in development.
Where would support help?
Broader device testing, product refinement, and distribution. We welcome conversations about technical evaluation, appropriate use cases, and the work needed before new markets or integrations.
What are we looking for?
Partners and investors who value useful software, thoughtful engineering, and clear milestones. Speak directly with the founder about fit, scope, and next steps.
Financial Verification & Unit Economics
Built independently.
Built independently.
Accounted for rigorously.
A conservative, evidence-backed view of founder capital, verified unit economics, and operational milestones. Detailed financial ledgers, transactional reconciliations, and capital reports are shared directly with qualified strategic partners upon formal inquiry.
30-second company snapshot
What is real today.
A concise, verifiable view of the current business. Figures are drawn from ARBH Labs’ first-party release and payment records; unavailable figures are never estimated.
LastDose and PulseTrace, each available as a signed stable release.
Deduplicated first-party delivery count for the current canonical releases.
Monthly, yearly, and lifetime access covering both applications.
Independent product studio seeking aligned distribution, licensing, and strategic capital.
Capital and partnership focus
Broader device validationSDK extractionProduct refinementDistribution
Engagement Tiers
Start a strategic discussion.
Choose a topic to initiate a direct conversation with the founder. We structure partnerships around clear milestones and technical deliverables.
Distribution
Discuss Distribution →
Distribution & Pilots
Evaluate our shipping Android applications for your user base, explore co-marketing opportunities, or structure an enterprise pilot for caregiver networks.
Technology
Discuss Licensing →
SDK & Technology Licensing
Discuss whether our on-device sensing technology could support your product. Licensing and SDK packaging would require a scoped technical evaluation.
Capital
Discuss Investment →
Strategic Capital
Discuss strategic seed or growth investment to accelerate SDK extraction, expand our device testing lab, and scale distribution across target markets.
Legal & Regulatory Notice: This overview is for informational and strategic discussion purposes only and does not constitute a public offer of securities, an investment solicitation, or a prospectus. Any commercial or investment agreement requires formal separate documentation. ARBH Labs software products are currently distributed for personal wellness and tracking purposes and are not certified medical devices.
Direct founder contact
Start with the right conversation.
Send a concise inquiry without leaving the page. ARBH Labs will use these details only to respond to this request.